The company has opened and moved into a 63,000 new sqft facility in the UK
Envair Technology factory at Heywood exterior
Containment specialist Envair Technology has opened a 63,000 sqft manufacturing site in Heywood, UK/
Envair has seen its revenue grow 92% within the last year. The company's new home represents a £1m ($1.4m) investment and will allow it to fulfil growing demand for containment technology.
The Heywood site, which complements existing sites in Middlewich and Albacete (Spain), will help Envair significantly increase production capacity. The new base of operations, the largest containment manufacturing facility in the North West of England, has the potential to double current output.
Envair Technology factory at Heywood interior
With this expanded capability, turnover is expected to reach more than £20m ($27.3m) in 2022 - with headcount also set to increase 15% to 150 staff.
The move consolidates the manufacturing of Envair's rigid containment product lines - TCS fume cupboards and Envair isolators - at one location. This has enabled the company to bring more of its manufacturing processes in-house to secure the supply chain, upskill workforce and increase R&D.
The Greater Manchester site was chosen due to its proximity to a unique containment technology talent pool found in the North West of England - which, in part, owes its origins to the legacy of a large historical pharmaceutical presence in the region.
The facility means Envair can continue to innovate its next-gen vaporised hydrogen peroxide rapid gassing isolators
Andrew Ellison, CEO of Envair Technology, said: "As we expand our operations, our new home will enable us to meet growing demand for containment solutions around the world. We are currently seeing growth being driven by various trends. This includes the impact of the COVID-19 pandemic, but there has also been a huge rise in the demand for personalised medicine globally, which has increased the number of healthcare and pharmaceutical personnel working with high potent compounds."
Ellison added that the new Heywood facility also means Envair can continue to innovate and develop new product lines - such as its next generation vaporised hydrogen peroxide (VHP) rapid gassing isolators.